Приказ основних података о документу

dc.contributorOzturk, Munir
dc.contributorEgamberdieva, Dilfuza
dc.contributorPešić, Milica
dc.creatorTovilović-Kovačević, Gordana
dc.creatorZogović, Nevena
dc.creatorKrstić Milošević, Dijana
dc.date.accessioned2020-09-25T11:30:26Z
dc.date.available2900-01-01
dc.date.issued2020
dc.identifier.isbn978-0-12-819541-3
dc.identifier.urihttps://radar.ibiss.bg.ac.rs/123456789/3896
dc.description.abstractGentianaceae have a long history of use as traditional remedies for treatment of various ailments. The medicinal properties of crude herbal drug are attributed to bitter glycosides, flavonoids, and xanthones, the main plant secondary metabolites. These plant-derived molecules, especially naturally occurring xanthones, possess a broad spectrum of bioactivity like anticarcinogenic, antimicrobial, neuroprotective, antidiabetic, cardio-protective. The most of Gentianaceae species are rare and endangered by uncontrolled overharvesting and influences of various environmental factors (habitat loss, climate change, and invasive species spreading). Decline of Gentianaceae species poses a high risk to the loss of enormous diversity of potentially bioactive compounds. In this chapter we will summarize pharmacological activities of identified secondary metabolites from endangered species belonging to four Gentianaceae genera (Gentiana, Gentianella, Centaurium, Swertia), as well as importance of biodiversity conservation in context of their biotherapeutic potential.en
dc.language.isoensr
dc.publisherAcademic Presssr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173053/RS//sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173015/RS//sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/41030/RS//sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200007/RS//sr
dc.rightsrestrictedAccesssr
dc.sourceBiodiversity and Biomedicine Our Futuresr
dc.subjectxanthonessr
dc.subjectiridoidssr
dc.subjectflavonoidssr
dc.subjectpharmacological activitysr
dc.subjectendangered speciessr
dc.subjectbiodiversitysr
dc.titleSecondary metabolites from endangered Gentiana, Gentianella, Centaurium, and Swertia species (Gentianaceae): promising natural biotherapeuticsen
dc.typebookPartsr
dc.rights.licenseARRsr
dcterms.abstractЗоговиц, Невена; Товиловић-Ковачевић, Гордана; Крстић-Милошевић, Дијана;
dc.rights.holder© 2020 Elsevier Inc.sr
dc.description.otherOzturk M, Egamberdieva D, Pešić M. Biodiversity and Biomedicine: Our Future. London: Academic Press; 2020. p. 335-84.
dc.identifier.doi10.1016/B978-0-12-819541-3.00019-0
dc.citation.apaTovilovic-Kovacevic, G., Zogovic, N., & Krstic-Milosevic, D. (2020). Secondary metabolites from endangered Gentiana, Gentianella, Centaurium, and Swertia species (Gentianaceae): promising natural biotherapeutics. In M. Ozturk, D. Egamberdieva, & M. Pešić (Eds.), Biodiversity and Biomedicine (pp. 335–384).
dc.citation.vancouverTovilovic-Kovacevic G, Zogovic N, Krstic-Milosevic D. Secondary metabolites from endangered Gentiana, Gentianella, Centaurium, and Swertia species (Gentianaceae): promising natural biotherapeutics. In: Ozturk M, Egamberdieva D, Pešić M, editors. Biodiversity and Biomedicine. London: Academic Press; 2020. p. 335–84.
dc.citation.spage335
dc.citation.epage384
dc.type.versionpublishedVersionsr
dc.citation.rankM13


Документи

Thumbnail
Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу